Novel Bcr-Abl1 Tyrosine Kinase Inhibitor (Tki) Hqp1351 (Olverembatinib) Is Efficacious And Well Tolerated In Patients With T315i-Mutated Chronic Myeloid Leukemia (Cml): Results Of Pivotal (Phase Ii) TrialsQian Jiang,Xiaojun Huang,Zi Chen,Qian Niu,Dayu Shi,Zongru Li,Yue Hou,Yu Hu,Weiming Li,Xiaoli Liu,Na Xu,Yongping Song,Yanli Zhang,Li Meng,Zhenya Hong,Bingcheng Liu,Shan Zeng,Lichuang Men,Yan Li,Suning Chen,Mengxing Xue,Huanling Zhu,He Li,Xin Du,Jin Lou,Xiaohan Zhang,Yang Liang,Yujun Dai,Ming Lu,Hengbang Wang,Jiao Ji, Changai Yue,Dajun Yang,Yifan ZhaiBLOOD（2020）引用 21|浏览72暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
